Cargando…

Increasing evidence for the efficacy of hepatic arterial infusion chemotherapy combined with systemic therapy for advanced hepatocellular carcinoma with macrovascular invasion: time to consider a more effective approach

Detalles Bibliográficos
Autores principales: Moriya, Kei, Nagamatsu, Shinsaku, Uejima, Masakazu, Matsuo, Hideki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643572/
https://www.ncbi.nlm.nih.gov/pubmed/37969841
http://dx.doi.org/10.21037/jgo-23-760
_version_ 1785147130662354944
author Moriya, Kei
Nagamatsu, Shinsaku
Uejima, Masakazu
Matsuo, Hideki
author_facet Moriya, Kei
Nagamatsu, Shinsaku
Uejima, Masakazu
Matsuo, Hideki
author_sort Moriya, Kei
collection PubMed
description
format Online
Article
Text
id pubmed-10643572
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-106435722023-11-15 Increasing evidence for the efficacy of hepatic arterial infusion chemotherapy combined with systemic therapy for advanced hepatocellular carcinoma with macrovascular invasion: time to consider a more effective approach Moriya, Kei Nagamatsu, Shinsaku Uejima, Masakazu Matsuo, Hideki J Gastrointest Oncol Editorial AME Publishing Company 2023-10-10 2023-10-31 /pmc/articles/PMC10643572/ /pubmed/37969841 http://dx.doi.org/10.21037/jgo-23-760 Text en 2023 Journal of Gastrointestinal Oncology. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Editorial
Moriya, Kei
Nagamatsu, Shinsaku
Uejima, Masakazu
Matsuo, Hideki
Increasing evidence for the efficacy of hepatic arterial infusion chemotherapy combined with systemic therapy for advanced hepatocellular carcinoma with macrovascular invasion: time to consider a more effective approach
title Increasing evidence for the efficacy of hepatic arterial infusion chemotherapy combined with systemic therapy for advanced hepatocellular carcinoma with macrovascular invasion: time to consider a more effective approach
title_full Increasing evidence for the efficacy of hepatic arterial infusion chemotherapy combined with systemic therapy for advanced hepatocellular carcinoma with macrovascular invasion: time to consider a more effective approach
title_fullStr Increasing evidence for the efficacy of hepatic arterial infusion chemotherapy combined with systemic therapy for advanced hepatocellular carcinoma with macrovascular invasion: time to consider a more effective approach
title_full_unstemmed Increasing evidence for the efficacy of hepatic arterial infusion chemotherapy combined with systemic therapy for advanced hepatocellular carcinoma with macrovascular invasion: time to consider a more effective approach
title_short Increasing evidence for the efficacy of hepatic arterial infusion chemotherapy combined with systemic therapy for advanced hepatocellular carcinoma with macrovascular invasion: time to consider a more effective approach
title_sort increasing evidence for the efficacy of hepatic arterial infusion chemotherapy combined with systemic therapy for advanced hepatocellular carcinoma with macrovascular invasion: time to consider a more effective approach
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643572/
https://www.ncbi.nlm.nih.gov/pubmed/37969841
http://dx.doi.org/10.21037/jgo-23-760
work_keys_str_mv AT moriyakei increasingevidencefortheefficacyofhepaticarterialinfusionchemotherapycombinedwithsystemictherapyforadvancedhepatocellularcarcinomawithmacrovascularinvasiontimetoconsideramoreeffectiveapproach
AT nagamatsushinsaku increasingevidencefortheefficacyofhepaticarterialinfusionchemotherapycombinedwithsystemictherapyforadvancedhepatocellularcarcinomawithmacrovascularinvasiontimetoconsideramoreeffectiveapproach
AT uejimamasakazu increasingevidencefortheefficacyofhepaticarterialinfusionchemotherapycombinedwithsystemictherapyforadvancedhepatocellularcarcinomawithmacrovascularinvasiontimetoconsideramoreeffectiveapproach
AT matsuohideki increasingevidencefortheefficacyofhepaticarterialinfusionchemotherapycombinedwithsystemictherapyforadvancedhepatocellularcarcinomawithmacrovascularinvasiontimetoconsideramoreeffectiveapproach